| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Op. &Scientific Officer | Chief Operating Officer
1 company
Miller Steve serves as a Chief Op. &Scientific Officer at CPRX. Across recent SEC filings that breaks down to 0 buys and 11 sells.
Historically, Miller Steve's trades have earned a middling insider score of 56/100 across 7 rated trades. Over a 12-month horizon, 66.7% of those trades were profitable, with an average 12-month return of -1.6%.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug 26, 2025 | CPRX Catalyst Pharmaceuticals, Inc. | Chief Op. &Scientific Officer | Sale+OE | 115,000 | $20.28 | $2,332,200.00 | -10.8% | +17.9% | - | |
| Dec 10, 2024 | CPRX Catalyst Pharmaceuticals, Inc. | Chief Op. &Scientific Officer | Sale+OE | 50,000 | $21.93 | $1,096,350.00 | -6.8% | -6.5% | +3.1% | |
| Aug 20, 2024 | CPRX Catalyst Pharmaceuticals, Inc. | Chief Op. &Scientific Officer | Sell | 150,000 | $20.35 | $3,052,900.00 | -18.2% | +0.6% | -1.7% | |
| Dec 5, 2023 | CPRX Catalyst Pharmaceuticals, Inc. | Chief Op. &Scientific Officer | Sell | 40,000 | $14.24 | $569,600.00 | -5.8% | +17.1% | +54.1% | |
| Nov 23, 2022 | CPRX Catalyst Pharmaceuticals, Inc. | Chief Operating Officer | Sell | 100,000 | $15.69 | $1,568,820.00 | -15.3% | -10.5% | -17.4% | |
| Sep 13, 2022 | CPRX Catalyst Pharmaceuticals, Inc. | Chief Operating Officer | Sell | 107,933 | $16.90 | $1,824,366.56 | -14.2% | +13.8% | -16.8% |